FDA approves cancer drug for personalized immunotherapy approach – Medical Xpress
Medical Xpress |
FDA approves cancer drug for personalized immunotherapy approach
Medical Xpress Experts at the Bloomberg–Kimmel Institute designed the first clinical trial to test the theory that patients whose tumors have defects in mismatch repair genes may respond better to immunotherapy. Results of the trial were presented and published in … SAA Funding Contributes to FDA Approval Of Keytruda Expanded Keytruda Approval Signals New Phase for Precision Medicine, May Benefit NGS Panel Makers |
